Introduction

Sedative, Hypnotic, or Anxiolytic Use Disorder: Symptoms, Causes, and Therapy Options

Sedative Disorder: Symptoms, Causes, and Therapy Options

Sedative, Hypnotic, or Anxiolytic Use Disorder (SHAUD) is a condition characterized by the problematic use of medications that have calming, sleep-inducing, or anxiety-relieving effects. These substances include sedatives (such as barbiturates), hypnotics (sleep medications like zolpidem), and anxiolytics (anti-anxiety drugs like benzodiazepines). These medications, while prescribed for valid medical reasons, can lead to dependence, tolerance, and addiction when misused.

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) classifies Sedative, Hypnotic, or Anxiolytic Use Disorder as the continued use of these substances despite negative consequences. SHAUD can cause significant impairments in personal, social, and professional functioning, and the misuse of these drugs carries a high risk of overdose and serious withdrawal symptoms. This article will cover Symptoms, Causes, and Therapy Options for SHAUD.

Go to our information directory on Mental Health Issues

Symptoms of Sedative, Hypnotic, or Anxiolytic Use Disorder

Symptoms of SHAUD include physical, behavioral, and psychological signs that indicate a problematic pattern of use. Below is a table outlining the common symptoms and examples of SHAUD:

Symptom	Description/Example
Craving or Compulsion to Use	The individual feels a strong desire or compulsion to use sedatives, hypnotics, or anxiolytics. For example, someone may feel the need to take extra doses of their anti-anxiety medication.
Tolerance	Needing to take increasingly higher doses to achieve the same effect. For instance, a person who once used a low dose of a sleeping pill may now need a much higher dose to fall asleep.
Withdrawal Symptoms	Physical or psychological symptoms such as anxiety, tremors, sweating, or seizures when not using the drug. A person may feel intense anxiety or irritability when reducing or stopping use.
Inability to Control Use	Repeated attempts to reduce or stop use are unsuccessful. For example, the individual might try to cut back on their use of benzodiazepines but relapse due to cravings or withdrawal symptoms.
Neglect of Responsibilities	The individual may neglect personal, professional, or social responsibilities due to substance use or withdrawal effects. This could include missing work because of sedation or sleepiness caused by drug use.
Continued Use Despite Negative Consequences	The person continues using the substance despite adverse consequences, such as relationship problems or health warnings from a doctor.

Causes and Risk Factors of Sedative, Hypnotic, or Anxiolytic Use Disorder

The development of SHAUD is influenced by a combination of genetic, psychological, and environmental factors.

Major causes that we will discuss, include: Genetic and Biological Factors, Psychological Factors, Environmental Factors:

1. Genetic and Biological Factors

Genetic predisposition plays a significant role in the development of SHAUD. Individuals with a family history of substance use disorders or mental health issues are at a higher risk of developing dependence on sedatives, hypnotics, or anxiolytics.

The GABAergic system is central to the action of sedatives and anxiolytics. These drugs enhance the activity of GABA, a neurotransmitter that inhibits brain activity, producing a calming effect. Prolonged use disrupts this system, leading to tolerance, dependence, and withdrawal symptoms.
Genetic factors related to dopamine regulation and GABA receptor sensitivity may increase an individual’s vulnerability to addiction, particularly when it comes to substances that act on the central nervous system.

John, diagnosed with Sedative Use Disorder, has a family history of alcoholism and substance abuse, which may have contributed to his vulnerability to sedative dependence.

2. Psychological Factors

Mental health conditions such as anxiety disorders, panic disorders, or insomnia are common contributors to SHAUD. Many individuals misuse sedatives or anxiolytics as a way to self-medicate for underlying psychological issues.

Self-medication hypothesis suggests that individuals with untreated or poorly managed mental health conditions may use sedatives or anxiolytics to alleviate symptoms like anxiety, panic, or insomnia. Over time, misuse leads to dependence and worsens the original condition.
Repeated use of these substances creates a cycle of reliance, where individuals feel unable to cope with their mental health without the medication, ultimately increasing the risk of addiction.

Sarah, diagnosed with Anxiolytic Use Disorder, started taking Xanax to manage her anxiety. While the medication initially helped, she became dependent on it to cope with everyday stress, and now she feels unable to function without it.

3. Environmental Factors

Environmental influences, such as easy access to prescription medications, peer pressure, or a history of substance misuse in the family, also contribute to the development of SHAUD.

Prescription availability is a significant factor in the development of SHAUD, especially when individuals have long-term prescriptions for sedatives or anxiolytics. Over time, individuals may misuse these medications by increasing their dose without consulting a healthcare provider.
Social or familial environments where substance use is normalized can increase the likelihood of misusing prescription medications.

Sarah, diagnosed with Anxiolytic Use Disorder, was given a long-term prescription for benzodiazepines. As her tolerance grew, she began using more than prescribed, eventually leading to addiction.

Therapy and Treatment Options for Sedative, Hypnotic, or Anxiolytic Use Disorder

Treating SHAUD requires a combination of medical intervention, psychotherapy, and behavioral therapies to address both the physical dependence and the psychological aspects of addiction.

1. Cognitive Behavioral Therapy (CBT)

Cognitive Behavioral Therapy (CBT) is a common treatment for SHAUD and focuses on identifying and changing the thought patterns and behaviors that contribute to substance use.

CBT helps individuals recognize the situations and stressors that trigger sedative or anxiolytic use. By developing healthier coping mechanisms, individuals can reduce their reliance on these substances.
Relapse prevention is a key part of CBT, which teaches individuals strategies to manage cravings and high-risk situations where they might be tempted to misuse medications.

John, diagnosed with Sedative Use Disorder, begins participating in Cognitive Behavioral Therapy (CBT) to address his underlying anxiety and sleep problems without resorting to sedatives. Through CBT, John works with his therapist to explore the patterns of thought and behavior that have led him to rely on sedatives as a way to cope with emotional distress and sleep issues.

2. Motivational Enhancement Therapy (MET)

Motivational Enhancement Therapy (MET) is a client-centered approach that helps individuals build the motivation to reduce or quit sedative or anxiolytic use. It is particularly useful for individuals who may be ambivalent about seeking treatment.

MET focuses on exploring the individual’s personal reasons for reducing or quitting substance use and developing a plan for change. The therapist helps the individual resolve ambivalence and commit to recovery.
MET is often used alongside CBT to improve treatment outcomes by enhancing the individual’s motivation to make lasting changes.

Sarah, initially hesitant to seek help for her Anxiolytic Use Disorder, begins participating in Motivational Enhancement Therapy (MET) to explore how her benzodiazepine use is affecting her relationships and health. MET is a client-centered, brief therapeutic approach designed to help individuals resolve ambivalence and increase motivation to change.

3. Dialectical Behavior Therapy (DBT)

Dialectical Behavior Therapy (DBT) is particularly useful for individuals with SHAUD who struggle with emotional dysregulation or co-occurring mental health conditions, such as anxiety or borderline personality disorder. DBT teaches skills for managing intense emotions and reducing impulsive behaviors.

DBT focuses on four key areas: emotional regulation, distress tolerance, mindfulness, and interpersonal effectiveness. These skills help individuals reduce their reliance on sedatives or anxiolytics to manage stress and emotions.
DBT is especially effective for individuals with co-occurring disorders who use sedatives to manage overwhelming emotions.

John, diagnosed with Sedative Use Disorder, participates in Dialectical Behavior Therapy (DBT) to learn how to manage his emotional responses without relying on sedatives. DBT, a form of therapy developed to treat individuals with emotion regulation difficulties, helps John develop healthier coping strategies and emotional resilience.

4. Medication-Assisted Therapy (MAT)

While medications are not typically used to treat SHAUD, medication-assisted therapy (MAT) may be used to help manage withdrawal symptoms during detoxification. Medications such as gabapentin or clonidine can help alleviate some of the physical symptoms of withdrawal.

MAT focuses on reducing withdrawal symptoms and making the detox process safer and more manageable. Medications like gabapentin can reduce anxiety, tremors, and seizures, which are common during sedative withdrawal.
Medical supervision is crucial during withdrawal, as sudden discontinuation of sedatives or anxiolytics can lead to life-threatening symptoms, including seizures.

Sarah, diagnosed with Anxiolytic Use Disorder, undergoes a medically supervised detox to safely taper off her use of benzodiazepines. As part of her treatment, she is closely monitored by medical professionals to ensure her safety during the withdrawal process. Benzodiazepine withdrawal can be challenging, and a medically supervised detox is crucial to managing potential risks such as seizures, intense anxiety, and other physical symptoms.

Long-Term Management of Sedative, Hypnotic, or Anxiolytic Use Disorder

Long-term management of SHAUD requires ongoing therapy, support, and lifestyle changes to prevent relapse and sustain recovery. Key strategies include:

Continued Therapy: Regular participation in CBT or DBT helps individuals maintain the skills they’ve developed during treatment and reduce the risk of relapse.
Support Groups: Joining a support group, such as Narcotics Anonymous (NA), provides individuals with a sense of community and accountability.
Relapse Prevention: Developing a solid relapse prevention plan, including identifying triggers and high-risk situations, helps individuals stay committed to their recovery and avoid returning to substance use.

Complete guide on Therapeutic Options

Conclusion

Sedative, Hypnotic, or Anxiolytic Use Disorder (SHAUD) is a serious condition that results from the misuse of medications intended to treat anxiety, insomnia, or other conditions. The causes of SHAUD include genetic, psychological, and environmental factors. Treatment typically involves Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), Dialectical Behavi o r Therapy (DBT), and in some cases, medication-assisted therapy (MAT) for withdrawal management. Long-term management strategies such as continued therapy, support group participation, and relapse prevention are essential for improving recovery outcomes and quality of life for individuals with SHAUD.